bharat biotech

The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July - August 2021 i.e increasing the production from 1 crore vaccine doses in April, 2021 to 6-7 crore vaccine dose/month in July – August.

Meanwhile, the cumulative number of COVID-19 vaccine doses administered in the country stands at 11,72,23,509 till today.

We took Covishield. We don't have any problems (after vaccination) and are in good health. I appeal to those who are eligible for vaccination to come forward to take the vaccine.

Bharat Biotech-developed indigenous vaccine, Covaxin which is now undergoing phase-3 trials, had raised concerns among experts over its emergency approval earlier this month by India's drug regulator.

Prime Minister Narendra Modi and chief ministers above the age of 50 will get vaccinated against COVID-19 in the next phase of the nationwide inoculation drive, said sources.

Capital India Finance Corp Chairman SK Narvar believes that India’s response to the pandemic has demonstrated our ability to successfully scale up our research, manufacturing, and distribution abilities at ultra-short notices. All this will help instil investors’ confidence in India’s potential as a global manufacturing hub.

Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the two "are safest of the vaccines".

"Mr. Adar Poonawala and Dr. Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture and supply the COVID-19 vaccines for India and globally," read a joint statement from SII and Bharat Biotech.

DCGI approved Oxford’s COVID-19 vaccine Covishield and Bharat Biotech’s Covaxin, PM Modi congratulated Indians.

Yesterday, India’s drug regulator granted emergency use of Coronavirus vaccine developed by Oxford University and AstraZeneca for emergency use.